Shenzhen Neptunus Bioengineering Co., Ltd.
|
36.41 Billion CNY
|
99.258%
|
Anhui Fengyuan Pharmaceutical Co., Ltd.
|
4.27 Billion CNY
|
93.676%
|
Dong-E-E-Jiao Co.,Ltd.
|
4.71 Billion CNY
|
94.265%
|
Livzon Pharmaceutical Group Inc.
|
12.27 Billion CNY
|
97.798%
|
Hainan Haiyao Co., Ltd.
|
1.45 Billion CNY
|
81.444%
|
Tus-Pharmaceutical Group Co., Ltd.
|
395.92 Million CNY
|
31.704%
|
Jilin Aodong Pharmaceutical Group Co., Ltd.
|
3.44 Billion CNY
|
92.16%
|
Changchun High-Tech Industries (Group) Inc.
|
14.46 Billion CNY
|
98.13%
|
Apeloa Pharmaceutical Co.,Ltd
|
11.47 Billion CNY
|
97.643%
|
PKU HealthCare Corp.,Ltd.
|
2.19 Billion CNY
|
87.674%
|
Chengdu Huasun Technology Group Inc., Ltd.
|
1 Billion CNY
|
73.051%
|
Dezhan Healthcare Company Limited
|
498.08 Million CNY
|
45.712%
|
Jinling Pharmaceutical Company Limited
|
2.78 Billion CNY
|
90.293%
|
Jiuzhitang Co., Ltd.
|
2.91 Billion CNY
|
90.738%
|
Huapont Life Sciences Co., Ltd.
|
11.59 Billion CNY
|
97.668%
|
Zhejiang Jingxin Pharmaceutical Co., Ltd.
|
3.95 Billion CNY
|
93.158%
|
Shandong Wohua Pharmaceutical Co., Ltd.
|
894.31 Million CNY
|
69.765%
|
Hengkang Medical Group Co., Ltd.
|
3.59 Billion CNY
|
92.469%
|
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
|
2.61 Billion CNY
|
89.642%
|
Qianjiang Yongan Pharmaceutical Co., Ltd.
|
962.8 Million CNY
|
71.915%
|
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
|
5.42 Billion CNY
|
95.013%
|
Jinhe Biotechnology CO., LTD.
|
2.17 Billion CNY
|
87.563%
|
Teyi Pharmaceutical Group Co.,Ltd
|
1.06 Billion CNY
|
74.663%
|
Kunming Longjin Pharmaceutical Co., Ltd.
|
86.62 Million CNY
|
-212.159%
|
Beijing Aosaikang Pharmaceutical Co., Ltd.
|
1.44 Billion CNY
|
81.267%
|
Chengdu Kanghong Pharmaceutical Group Co., Ltd
|
3.95 Billion CNY
|
93.167%
|
Anhui Huangshan Capsule Co., Ltd.
|
458.36 Million CNY
|
41.008%
|
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd
|
980.82 Million CNY
|
72.431%
|
Zhuhai Rundu Pharmaceutical Co., Ltd.
|
1.29 Billion CNY
|
79.069%
|
Huaren Pharmaceutical Co., Ltd.
|
1.63 Billion CNY
|
83.474%
|
Tianjin Ringpu Bio-Technology Co.,Ltd.
|
2.24 Billion CNY
|
87.977%
|
Shanxi Zhendong Pharmaceutical Co.,Ltd
|
3.62 Billion CNY
|
92.543%
|
Fuan Pharmaceutical (Group) Co., Ltd.
|
2.64 Billion CNY
|
89.788%
|
Hybio Pharmaceutical Co., Ltd.
|
431.38 Million CNY
|
37.318%
|
Baotou Dongbao Bio-Tech Co.,Ltd
|
974.51 Million CNY
|
72.253%
|
Hunan Er-Kang Pharmaceutical Co., Ltd
|
1.76 Billion CNY
|
84.716%
|
Changjiang Pharmaceutical Group Co., Ltd.
|
1.19 Billion CNY
|
77.421%
|
Zhejiang Garden Bio-chemical High-tech Co., Ltd.
|
1.09 Billion CNY
|
75.298%
|
Fujian Cosunter Pharmaceutical Co., Ltd.
|
422.71 Million CNY
|
36.033%
|
Beijing Science Sun Pharmaceutical Co., Ltd.
|
476.56 Million CNY
|
43.261%
|
Hainan Poly Pharm. Co., Ltd
|
1.3 Billion CNY
|
79.271%
|
Jiangxi Synergy Pharmaceutical Co., Ltd.
|
722.13 Million CNY
|
62.556%
|
Wuhan Hiteck Biological Pharma Co.,Ltd
|
602.28 Million CNY
|
55.104%
|
Shandong Xinhua Pharmaceutical Company Limited
|
8 Billion CNY
|
96.624%
|
Zhejiang Tianyu Pharmaceutical Co., Ltd.
|
2.52 Billion CNY
|
89.301%
|
PharmaBlock Sciences (Nanjing), Inc.
|
1.72 Billion CNY
|
84.327%
|
Jinghua Pharmaceutical Group Co., Ltd.
|
1.49 Billion CNY
|
81.858%
|
Zhejiang Hisoar Pharmaceutical Co., Ltd.
|
2.17 Billion CNY
|
87.55%
|
Betta Pharmaceuticals Co., Ltd.
|
2.45 Billion CNY
|
88.991%
|
Tibet AIM Pharm. Inc.
|
667.03 Million CNY
|
59.463%
|
Shenzhen Kangtai Biological Products Co., Ltd.
|
3.47 Billion CNY
|
92.224%
|
Shandong Shanda Wit Science and Technology Co., Ltd.
|
2.48 Billion CNY
|
89.115%
|
Pacific Shuanglin Bio-pharmacy Co., LTD
|
2.32 Billion CNY
|
88.388%
|
Zhejiang AngLiKang Pharmaceutical CO.,LTD.
|
1.62 Billion CNY
|
83.369%
|
Xiamen Kingdomway Group Company
|
3.1 Billion CNY
|
91.285%
|
ShanXi C&Y Pharmaceutical Group Co., Ltd.
|
799.3 Million CNY
|
66.171%
|
Walvax Biotechnology Co., Ltd.
|
4.11 Billion CNY
|
93.427%
|
Sunflower Pharmaceutical Group Co.,Ltd
|
5.63 Billion CNY
|
95.199%
|
Harbin Gloria Pharmaceuticals Co., Ltd
|
2.58 Billion CNY
|
89.56%
|
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
|
24.73 Billion CNY
|
98.907%
|
Hunan Hansen Pharmaceutical Co., Ltd.
|
955.53 Million CNY
|
71.702%
|
Changzhou Qianhong Biopharma CO.,LTD
|
1.79 Billion CNY
|
84.926%
|
Shenzhen Weiguang Biological Products Co., Ltd.
|
1.04 Billion CNY
|
74.211%
|
Honz Pharmaceutical Co., Ltd.
|
739.56 Million CNY
|
63.438%
|
Northeast Pharmaceutical Group Co., Ltd.
|
8.16 Billion CNY
|
96.687%
|
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
|
1.46 Billion CNY
|
81.513%
|
Guizhou Xinbang Pharmaceutical Co., Ltd.
|
6.46 Billion CNY
|
95.815%
|
Tianjin Lisheng Pharmaceutical Co.,Ltd.
|
1.13 Billion CNY
|
76.074%
|
Zhejiang Yatai Pharmaceutical Co., Ltd.
|
420.64 Million CNY
|
35.718%
|
Zhejiang NHU Company Ltd.
|
15.11 Billion CNY
|
98.211%
|
ApicHope Pharmaceutical Co., Ltd
|
2.5 Billion CNY
|
89.199%
|
Shanghai Kaibao Pharmaceutical CO.,Ltd
|
1.59 Billion CNY
|
83.037%
|
Beijing SL Pharmaceutical Co., Ltd.
|
1.01 Billion CNY
|
73.447%
|
Yunnan Baiyao Group Co.,Ltd
|
38.9 Billion CNY
|
99.305%
|
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD
|
1.08 Billion CNY
|
74.964%
|
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.
|
839.25 Million CNY
|
67.781%
|
Guangdong Lifestrong Pharmacy Co., Ltd.
|
292.39 Million CNY
|
7.523%
|
Huadong Medicine Co., Ltd
|
40.39 Billion CNY
|
99.331%
|
Jiangsu Nhwa Pharmaceutical Co., LTD
|
4.97 Billion CNY
|
94.563%
|
Harbin Medisan Pharmaceutical Co., Ltd.
|
1.18 Billion CNY
|
77.216%
|
LanZhou Foci Pharmaceutical Co.,Ltd.
|
1.16 Billion CNY
|
76.752%
|
Tianjin Chase Sun Pharmaceutical Co.,Ltd
|
6.12 Billion CNY
|
95.587%
|
Beijing Beilu Pharmaceutical Co., Ltd
|
890.71 Million CNY
|
69.642%
|
Nanjing Hicin Pharmaceutical Co., Ltd.
|
517.83 Million CNY
|
47.782%
|
Renhe Pharmacy Co., Ltd.
|
5.03 Billion CNY
|
94.627%
|
Chongqing Pharscin Pharmaceutical Co., Ltd.
|
691.54 Million CNY
|
60.899%
|
Zhejiang Xianju Pharmaceutical Co.,Ltd.
|
4.12 Billion CNY
|
93.442%
|
Luoxin Pharmaceuticals Group Stock Co., Ltd.
|
2.34 Billion CNY
|
88.457%
|
Guizhou Bailing Group Pharmaceutical Co., Ltd.
|
4.26 Billion CNY
|
93.657%
|